Evidence map›Paper›PMID 33576445›Full record

ArticleMolecular medicine reports2021

lncRNA‑MALAT1 promotes high glucose‑induced H9C2 cardiomyocyte pyroptosis by downregulating miR‑141‑3p expression.

Aishan Wu, Weili Sun, Fengying Mou

Open access · hybridAbstract read
In one paragraph

Article in Molecular medicine reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 2 pooled it
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 2 syntheses or guidelines pooled it, 51 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. MALAT1-miR-20b-5p-P2RX7 Axis RegulatesVeterinary sciences · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Aishan WuDepartment of Cardiology II, Weihai Municipal Hospital, Weihai, Shandong 264200, P.R. China.
Weili SunDepartment of Anesthesiology, Weihai Municipal Hospital, Weihai, Shandong 264200, P.R. China.
Fengying MouDepartment of Ultrasound, Weifang People's Hospital, Weifang, Shandong 261041, P.R. China.
Weihai Municipal Hospital · CNWeifang People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetic cardiomyopathy (DCM) is caused by diabetes and can result in heart failure. Long non‑coding RNAs (lncRNAs) have been demonstrated to be closely associated with DCM development. The present study aimed to investigate whether lncRNA‑metastasis‑associated lung adenocarcinoma transcript‑1 (MALAT1) altered high glucose (HG)‑induced H9C2 cardiomyocyte pyroptosis by targeting microRNA (miR)‑141‑3p. H9C2 cells were treated with normal glucose (NG) or HG. lncRNA‑MALAT1 and miR‑141‑3p expression levels were determined via reverse transcription‑quantitative PCR (RT‑qPCR). MALAT1 and miR‑141‑3p knockdown and overexpression were established and confirmed via RT‑qPCR. The association between MALAT1 expression and miR‑141‑3p expression, as well as the induction of pyroptosis and gasdermin D (GSDMD)‑N expression were evaluated by performing dual luciferase reporter, TUNEL staining and immunofluorescence staining assays, respectively. Western blotting was conducted to measure the expression levels of pyroptosis‑associated proteins, including apoptosis‑associated speck‑like protein, GSDMD‑N, caspase‑1, nucleotide oligomerization domain‑like receptor protein 3 and GSDMD. MALAT1 mRNA expression levels were significantly increased, whereas miR‑141‑3p expression levels were significantly decreased in HG‑treated H9C2 cells compared with the NG group. Compared with the HG group, MALAT1 overexpression significantly reduced miR‑141‑3p expression levels, increased the rate of TUNEL positive cells and upregulated the expression levels of pyroptosis‑associated proteins. MALAT1 knockdown displayed the opposite effect on the rate of TUNEL positive cells and the expression levels of pyroptosis‑associated proteins. Furthermore, the rate of TUNEL positive cells, and GSDMD‑N and pyroptosis‑associated protein expression levels were significantly reduced by miR‑141‑3p overexpression in MALAT1‑overexpression H9C2 cells. The results indicated that compared with NG treatment, HG treatment increased MALAT1 expression levels and decreased miR‑141‑3p expression levels in H9C2 cells. Therefore, the present study suggested that lncRNA‑MALAT1 targeted miR‑141‑3p to promote HG‑induced H9C2 cardiomyocyte pyroptosis.

Indexed as

Gene Expression RegulationAnimalsCaspase 1Cell LineDose-Response Relationship, DrugDown-RegulationGasderminsGlucoseIntracellular Signaling Peptides and ProteinsMicroRNAsMyocytes, CardiacNLR Family, Pyrin Domain-Containing 3 ProteinPhosphate-Binding ProteinsPyroptosisRatsRNA, Long NoncodingCaspase 1GasderminsGlucoseGsdmd protein, ratIntracellular Signaling Peptides and ProteinsMALAT1 long noncoding RNA, ratMicroRNAsMirn141 microRNA, ratNLR Family, Pyrin Domain-Containing 3 ProteinPhosphate-Binding ProteinsRNA, Long NoncodingcardiomyocytesH9C2high glucoselong non‑coding RNA‑metastasis‑associated lung adenocarcinoma transcript‑1microRNA‑141‑3ppyroptosis

Identifiers

PMID33576445
PMCPMC7893681
OpenAlexW3126314545

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.